SCOTT MASULLO: Open Payments
NPI 1568189322 · BLOOMFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 67 payments from 15 companies in 2025. Trend: 2023 $786 · 2024 $889 · 2025 $1,036
Food & beverage: $1,036
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $207 |
| PFIZER INC. | 14 | $183 |
| AstraZeneca Pharmaceuticals LP | 11 | $161 |
| Corcept Therapeutics | 5 | $107 |
| Novo Nordisk Inc | 4 | $78 |
| Kowa Pharmaceuticals America, Inc. | 4 | $59 |
| KYOWA KIRIN, INC. | 3 | $54 |
| Bausch Health US, LLC | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| BioCryst US Sales Co., LLC | 1 | $18 |
Products named: Korlym, BREZTRI, VRAYLAR, UBRELVY, NURTEC ODT, ZORYVE, CRYSVITA, ELIQUIS.
Industry payments across NJ — which companies pay providers there.
